Abstract | PROBLEM: METHOD OF STUDY: Seventy-five healthy pregnant women used as controls and 25 preselected pregnant patients with either SLE and/or APS were enrolled in the study. Study patients were in remission during conception and all patients agreed to give 5 ml of venous blood at midgestation. The samples were frozen and analyzed retrospectively. After delivery, pregnancy outcomes were gathered from hospital records. RESULTS: Seventeen (68%) women had uneventful pregnancies and deliveries (normal) whereas 8 (32%) showed pathologic obstetric outcomes. Mean midgestational serum PLF levels were similar in the control and normal outcome groups (87 U/ml), whereas significantly lower levels (37 U/ml) were measured in the pathologic outcome group. Using a cutoff level of 10 U/ml, 85% from the normal outcome group and 15% from the pathologic outcome group were above this threshold level, with 60% specificity and 100% sensitivity. CONCLUSIONS: These preliminary data suggest that PLF values may reflect placento-vascular functions. These may represent a predictive biomarker for developing obstetric complications in pregnant women with either SLE and/or APS.
|
Authors | R Maymon, J Bar, D Sherman, C Moroz |
Journal | American journal of reproductive immunology (New York, N.Y. : 1989)
(Am J Reprod Immunol)
Vol. 40
Issue 2
Pg. 95-101
(Aug 1998)
ISSN: 1046-7408 [Print] Denmark |
PMID | 9764351
(Publication Type: Journal Article)
|
Chemical References |
- Immunosuppressive Agents
- Ferritins
|
Topics |
- Adult
- Antiphospholipid Syndrome
(complications, immunology)
- Female
- Ferritins
(analysis)
- Humans
- Immunosuppressive Agents
(analysis)
- Lupus Erythematosus, Systemic
(complications, immunology)
- Placenta
(chemistry)
- Pregnancy
- Pregnancy Complications
(immunology)
- Pregnancy Outcome
- Retrospective Studies
|